BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27915304)

  • 1. Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality?
    Dragonetti G; Criscuolo M; Fianchi L; Pagano L
    Med Mycol; 2017 Jan; 55(1):82-86. PubMed ID: 27915304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study.
    Del Principe MI; Dragonetti G; Verga L; Candoni A; Marchesi F; Cattaneo C; Delia M; Potenza L; Farina F; Ballanti S; Decembrino N; Castagnola C; Nadali G; Fanci R; Orciulo E; Veggia B; Offidani M; Melillo L; Manetta S; Tumbarello M; Venditti A; Busca A; Aversa F; Pagano L;
    J Antimicrob Chemother; 2019 Apr; 74(4):1062-1068. PubMed ID: 30649413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell'Adulto, Gruppo Italiano Trapianto di Midollo Osseo, Associazione Italiana Ematologia ed Oncologia Pediatrica, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Sorveglianza Epidemiologica delle Infezioni Fungine nelle Emopatie Maligne.
    Girmenia C; Aversa F; Busca A; Candoni A; Cesaro S; Luppi M; Pagano L; Rossi G; Venditti A; Nosari AM; ; ; ; ;
    Hematol Oncol; 2013 Sep; 31(3):117-26. PubMed ID: 23037867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.
    Koehler P; Hamprecht A; Bader O; Bekeredjian-Ding I; Buchheidt D; Doelken G; Elias J; Haase G; Hahn-Ast C; Karthaus M; Kekulé A; Keller P; Kiehl M; Krause SW; Krämer C; Neumann S; Rohde H; La Rosée P; Ruhnke M; Schafhausen P; Schalk E; Schulz K; Schwartz S; Silling G; Staib P; Ullmann A; Vergoulidou M; Weber T; Cornely OA; Vehreschild MJ
    Int J Antimicrob Agents; 2017 Feb; 49(2):218-223. PubMed ID: 27989379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia.
    Le Clech L; Uguen M; Quinio D; Nevez G; Couturier MA; Ianotto JC; Berthou C; Guillerm G; Le Bars H; Payan C; Narbonne V; Baron R; Saliou P
    Curr Res Transl Med; 2020 Jan; 68(1):23-28. PubMed ID: 31787568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis--case analysis to plan better targeted prophylactic or therapeutic measurement.
    Babor F; Schuster F; Mackenzie C; Meisel R; Schaper J; Sabir H; Siepermann M; Wessalowski R; Janßen G; Borkhardt A; Laws HJ
    Klin Padiatr; 2012 Apr; 224(3):160-5. PubMed ID: 22504775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapsed and secondary disease drive the risk profile for invasive aspergillosis prior to stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome.
    van de Peppel RJ; Dekkers OM; von dem Borne PA; de Boer MG
    Med Mycol; 2014 Oct; 52(7):699-705. PubMed ID: 25049037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
    Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and outcome of invasive fungal infections in pediatric acute myeloid leukemia patients in a medical center in Taiwan.
    Lin GL; Chang HH; Lu CY; Chen CM; Lu MY; Lee PI; Jou ST; Yang YL; Huang LM; Chang LY
    J Microbiol Immunol Infect; 2018 Apr; 51(2):251-259. PubMed ID: 28089099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey.
    Del Principe MI; Dragonetti G; Conti A; Verga L; Ballanti S; Fanci R; Candoni A; Marchesi F; Cattaneo C; Lessi F; Fracchiolla N; Spolzino A; Prezioso L; Delia M; Potenza L; Decembrino N; Castagnola C; Nadali G; Picardi M; Zama D; Orciulo E; Veggia B; Garzia M; Dargenio M; Melillo L; Manetta S; Russo D; Mancini V; Piedimonte M; Tisi MC; Toschi N; Busca A; Pagano L; ;
    Mycoses; 2022 Feb; 65(2):171-177. PubMed ID: 34695256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry.
    Pagano L; Caira M; Candoni A; Aversa F; Castagnola C; Caramatti C; Cattaneo C; Delia M; De Paolis MR; Di Blasi R; Di Caprio L; Fanci R; Garzia M; Martino B; Melillo L; Mitra ME; Nadali G; Nosari A; Picardi M; Potenza L; Salutari P; Trecarichi EM; Tumbarello M; Verga L; Vianelli N; Busca A;
    Clin Infect Dis; 2012 Dec; 55(11):1515-21. PubMed ID: 22955439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort.
    Vehreschild JJ; Rüping MJ; Wisplinghoff H; Farowski F; Steinbach A; Sims R; Stollorz A; Kreuzer KA; Hallek M; Bangard C; Cornely OA
    J Antimicrob Chemother; 2010 Jul; 65(7):1466-71. PubMed ID: 20410061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in the Outcome of Invasive Aspergillosis in a Pediatric Hematology Department: A 10-Year Review.
    Domenech C; Leick-Courtois C; Bienvenu AL; Pracros JP; Picot S; Bleyzac N; Bertrand Y
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):560-5. PubMed ID: 26165404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole.
    Michallet M; Sobh M; Morisset S; Kraghel S; Nicolini FE; Thomas X; Bienvenu AL; Picot S; Nicolle MC; Vanhems P
    Med Mycol; 2011 Oct; 49(7):681-7. PubMed ID: 21314250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study).
    Candoni A; Farina F; Perruccio K; Di Blasi R; Criscuolo M; Cattaneo C; Delia M; Zannier ME; Dragonetti G; Fanci R; Martino B; Del Principe MI; Fianchi L; Vianelli N; Chierichini A; Garzia M; Petruzzellis G; Nadali G; Verga L; Busca A; Pagano L
    Mycoses; 2020 Oct; 63(10):1094-1100. PubMed ID: 32697010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey.
    Lanternier F; Seidel D; Pagano L; Styczynski J; Mikulska M; Pulcini C; Maertens J; Munoz P; Garcia-Vidal C; Rijnders B; Arendrup MC; Sabino R; Verissimo C; Gaustad P; Klimko N; Arikan-Akdagli S; Arsic V; Barac A; Skiada A; Klingspor L; Herbrecht R; Donnelly P; Cornely OA; Lass-Flörl C; Lortholary O
    Mycoses; 2020 May; 63(5):420-429. PubMed ID: 32009262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
    Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
    Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
    Dahlén T; Kalin M; Cederlund K; Nordlander A; Björkholm M; Ljungman P; Blennow O
    Eur J Haematol; 2016 Feb; 96(2):175-80. PubMed ID: 25880378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study.
    Kim SB; Cho SY; Lee DG; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH; Lee JW
    Med Mycol; 2017 Apr; 55(3):237-245. PubMed ID: 27562861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful allogeneic stem cell transplantation in two patients with acute myelogenous leukaemia and invasive aspergillosis by antifungal combination therapy.
    Aoki T; Miyamoto T; Mori Y; Yoshimoto G; Yamauchi T; Kamezaki K; Takenaka K; Iwasaki H; Harada N; Nagafuji K; Shimono N; Teshima T; Akashi K
    Mycoses; 2011 Jul; 54(4):e255-9. PubMed ID: 20236243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.